Last reviewed · How we verify
placebo of Bacillus Calmette - Guerin — Competitive Intelligence Brief
phase 3
Infectious Diseases
Biologic
Live · refreshed every 30 min
Target snapshot
placebo of Bacillus Calmette - Guerin (placebo of Bacillus Calmette - Guerin) — Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.. The Bacillus Calmette-Guérin (BCG) vaccine is a live attenuated vaccine that stimulates a cell-mediated immune response against Mycobacterium tuberculosis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| placebo of Bacillus Calmette - Guerin TARGET | placebo of Bacillus Calmette - Guerin | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- placebo of Bacillus Calmette - Guerin CI watch — RSS
- placebo of Bacillus Calmette - Guerin CI watch — Atom
- placebo of Bacillus Calmette - Guerin CI watch — JSON
- placebo of Bacillus Calmette - Guerin alone — RSS
Cite this brief
Drug Landscape (2026). placebo of Bacillus Calmette - Guerin — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-bacillus-calmette-guerin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab